TWIST1 controls cellular senescence and energy metabolism in mesenchymal stem cells

C Voskamp, L A Anderson, W J Koevoet

  • 1Department of Orthopaedics and Sports Medicine, Erasmus MC, 3015 CN Rotterdam, the Netherlands.r.narcisi@erasmusmc.nl.

European Cells & Materials
|November 26, 2021
PubMed

Insights

Silencing TWIST1 in mesenchymal stem cells (MSCs) accelerates senescence and alters their metabolic profile, impacting regenerative medicine potential. This specific senescence differs from irradiation-induced aging.

Area of Science:

  • Cell Biology
  • Regenerative Medicine
  • Stem Cell Biology

Background:

  • Mesenchymal stem cells (MSCs) hold promise for regenerative medicine due to their differentiation potential.
  • Cellular senescence and the senescence-associated secretory phenotype (SASP) impede the clinical application of MSCs.
  • The transcription factor TWIST1 is known to influence MSC expansion.

Purpose of the Study:

  • To investigate the role of TWIST1 in regulating cellular senescence in MSCs.
  • To characterize the senescence-associated secretory phenotype (SASP) and metabolic state of TWIST1-silencing-induced senescent MSCs.

Main Methods:

  • Silencing of the TWIST1 gene in MSCs.
  • Characterization of senescence markers and SASP profiles.
  • Assessment of cellular bioenergetics using Seahorse XF analysis.

Main Results:

  • TWIST1 silencing significantly increased senescence occurrence in MSCs.
  • TWIST1-silencing-induced senescence exhibited a distinct SASP profile compared to irradiation-induced senescence.
  • Both TWIST1-silencing-induced and irradiation-induced senescent MSCs showed elevated oxygen consumption rates.
  • TWIST1-silencing-induced senescent MSCs displayed a lower extracellular acidification rate than irradiation-induced senescent MSCs.

Conclusions:

  • TWIST1 plays a crucial role in regulating senescence in MSCs.
  • TWIST1 silencing induces a unique form of senescence with a specific SASP and metabolic signature.
  • Understanding TWIST1's role in MSC senescence is vital for advancing regenerative medicine therapies.

Related Concept Videos

Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.1K
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.2K
Tissue Renewal without Stem Cells01:23

Tissue Renewal without Stem Cells

After cellular or tissue damage, the resident stem cells present in the human body can locally repair and regenerate the damaged tissue or organ. However, even though some tissues do not have stem cells, they can repair and regenerate with the help of pre-existing cells. For example, beta cells of the pancreas and hepatocytes of the liver can divide to renew and regenerate the tissue. Here, both cell division and cell death are well regulated by homeostasis.
However, failure of such a system...
1.9K
Renewal of Intestinal Stem Cells01:23

Renewal of Intestinal Stem Cells

The intestinal epithelial lining rapidly renews every 4 to 5 days. The renewal is facilitated by intestinal stem cells (ISCs) located at the base of the crypt– a gland located at the bottom of each villus. ISCs divide asymmetrically to form new stem cells and progenitor daughter cells. The daughter cells are called transit-amplifying (TA) cells which move upwards along the crypt and either differentiate into absorptive cells– the enterocytes or secretory cells– including the...
2.8K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.1K
Adult Stem Cells01:33

Adult Stem Cells

Stem cells are undifferentiated cells that divide and produce more stem cells or progenitor cells that differentiate into mature, specialized cell types. All the cells in the body are generated from stem cells in the early embryo, but small populations of stem cells are also present in many adult tissues including the bone marrow, brain, skin, and gut. These adult stem cells typically produce the various cell types found in that tissue—to replace cells that are damaged or to continuously...
30.8K